Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9617328 Fusion protein having factor IX activity

Patent 9617328 was granted and assigned to SK Chemicals on April, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Mahn Hoon Park0

Yun Jung Lim0

Bong-yong Lee0

Hun-Taek Kim0

Min Sun Lee0

Date of Patent

April 11, 2017

Patent Application Number

13880239

Date Filed

October 19, 2011

Patent Citations Received

US Patent 11820807 Immunoglobulin fusion proteins and uses thereof

0

Patent Primary Examiner

Patent abstract

Disclosed is a fusion protein comprising blood coagulation factor IX (FIX) and transferrin. The fusion protein exhibits improved specific FIX activity, as compared to native FIX, and can be useful in the treatment of FIX deficiency-associated diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9617328 Fusion protein having factor IX activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.